Kahn Brothers Group Inc’s Pfizer Inc Position
Does Kahn Brothers Group Inc own Pfizer Inc (PFE)? Yes — 484.7K shares worth $14M (+2.41% of its 13F portfolio) as of Q1 2026, down from 554.0K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
484.7K
% of Portfolio
+2.41%
Quarters Held
30
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 484.7K | $14M | +2.41% |
| Q4 2025 | 554.0K | $14M | +2.44% |
| Q3 2025 | 707.1K | $18M | +3.39% |
| Q2 2025 | 731.0K | $18M | +3.56% |
| Q1 2025 | 735.2K | $19M | +3.77% |
| Q4 2024 | 761.1K | $20M | +4.39% |
| Q3 2024 | 997.0K | $29M | +4.97% |
| Q2 2024 | 1.00M | $28M | +4.71% |
| Q1 2024 | 1.02M | $28M | +4.21% |
| Q4 2023 | 1.03M | $30M | +4.65% |
| Q3 2023 | 1.06M | $35M | +5.46% |
| Q2 2023 | 1.07M | $39M | +5.73% |
| Q1 2023 | 1.03M | $42M | +6.05% |
| Q4 2022 | 1.04M | $53M | +7.00% |
| Q3 2022 | 1.04M | $45.6B | +7.11% |
| Q2 2022 | 1.05M | $54.9B | +7.39% |
| Q1 2022 | 1.04M | $53.9B | +6.85% |
| Q4 2021 | 1.02M | $60.1B | +8.26% |
| Q3 2021 | 981.0K | $42.2B | +5.94% |
| Q2 2021 | 824.5K | $32.3B | +4.62% |
| Q1 2021 | 662.3K | $24.0B | +3.71% |
| Q4 2020 | 674.7K | $24.8B | +4.33% |
| Q3 2020 | 692.5K | $25.4B | +4.82% |
| Q2 2020 | 764.5K | $25.0B | +4.22% |
| Q1 2020 | 770.3K | $25.1B | +4.60% |
| Q4 2019 | 809.8K | $31.7B | +3.85% |
| Q3 2019 | 811.8K | $29.2B | +3.66% |
| Q2 2019 | 806.0K | $34.9B | +4.37% |
| Q1 2019 | 533.6K | $22.7B | +3.54% |
| Q4 2018 | 534.4K | $23.3B | +4.21% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kahn Brothers Group Inc’s full portfolio or all institutional holders of PFE.